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Abstract
Efforts to control spread of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) are often based on eradication
of colonization. However, the role of nasal and non-nasal colonization in the pathogenesis of these infections remains poorly understood.
Patients with acute S. aureus skin and soft tissue infection (SSTI) were prospectively enrolled. Each subject’s nasal, axillary, inguinal and
rectal areas were swabbed for S. aureus and epidemiological risk factors were surveyed. Among the 117 patients enrolled, there were 99
patients who had an SSTI and for whom data could be analysed. Sixty-five patients had a CA-MRSA SSTI. Among these patients, MRSA
colonization in the nares, axilla, inguinal area and rectum was 25, 6, 11 and 13%, respectively, and 37% overall were MRSA colonized.
Most (96%) MRSA colonization was detected using nose and inguinal screening alone. Non-nasal colonization was 25% among CA-MRSA
patients, but only 6% among patients with CA-methicillin-susceptible S. aureus (MSSA) or healthcare-associated MRSA or MSSA. These
findings suggest that colonization patterns in CA-MRSA infection are distinct from those in non-CA-MRSA S. aureus infections. The rela-
tively high prevalence of non-nasal colonization may play a key role in CA-MRSA transmission and acquisition of infection.
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Introduction
Over the past decade, community-acquired methicillin-
resistant Staphylococcus aureus (CA-MRSA) infections have
emerged in persons without traditional MRSA risk factors.
Previous studies on the pathogenesis and spread of MRSA
have demonstrated that colonization with MRSA is a critical
risk factor for subsequent healthcare-associated MRSA infec-
tion [1], but to date there are very few data on patients with
CA-MRSA.
Staphylococcus aureus colonization is most consistently
identified in humans in the anterior nares. However, recent
studies of patients with CA-MRSA infection in outbreaks
have shown a significant number of infected patients without
colonization at that site [2,3]. Understanding body site
colonization in patients with CA-MRSA infection may be of
critical importance. For example, interventions to eradicate
colonization and prevent CA-MRSA infection often target
non-nasal sites, yet there are few data on non-nasal coloniza-
tion among patients with CA-MRSA.
We hypothesized that patients with CA-MRSA skin
infections might be colonized at body site locations other
than the anterior nares. This hypothesis is supported by
previous studies that have shown CA-MRSA spread via sex-
ual contact in both a heterosexual couple and men who
have sex with men [4,5]. We examined the prevalence of
MRSA colonization at four body sites to elucidate further
the relationship between MRSA colonization and infection in
patients with CA-MRSA and other types of S. aureus skin
infections.
Materials and Methods
From February 2005 to October 2007, we enrolled patients
with acute S. aureus skin infections from two clinical sources:
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(i) a 400-bed tertiary care county hospital (Harbor-UCLA
Medical Center) and (ii) outpatients at the human immuno-
deficiency virus (HIV) clinic associated with this medical cen-
tre. Inpatients were identified (on all days when a clinical
investigator was available) by screening of the clinical micro-
biology laboratory for new cultures positive for S. aureus
from a wound source. We attempted to enrol all patients
with acute S. aureus skin and soft tissue infections (SSTIs)
requiring hospitalization. Patients were eligible if: (i) the cul-
ture was positive for S. aureus, identified by a rapid S. aureus-
specific latex agglutination test (Staphaurex; Remel, Lenexa,
KS, USA), (ii) the patient was still hospitalized, and (iii) the
culture had been taken within 72 h of admission. Patients
with both methicillin-sensitive and methicillin-resistant
S. aureus were included, because patients were enrolled
before antibiotic susceptibility testing had been carried out.
HIV-infected outpatients were eligible if: (i) they had a clinical
condition consistent with a S. aureus infection, and (ii) a cul-
ture could be obtained from the patient. Outpatients were
offered a small financial incentive to participate in the survey
and colonization site sampling portions of the study.
Patients were excluded from the study if: (i) S. aureus had
been previously isolated from the patient during the current
hospitalization; (ii) the patient had already been enrolled in
the study; or (iii) the subject had previously refused to
participate in the study. Study staff approached all eligible
patients, described the study, and attempted to complete the
informed consent process. The study design was approved
by the Institutional Review Board at Harbor-UCLA Medical
Center.
Data collection
A standardized questionnaire was administered to all
consenting patients. This questionnaire used items from a
previous investigation of CA-MRSA risk factors [6], and sur-
veyed subjects about exposures previously associated with
healthcare-associated (HA)-MRSA infection [1,7] or with
CA-MRSA infection [4,8–12]. We also collected information
about clinical and demographic factors using a standardized
abstraction instrument described previously [6]. These
included age, gender, race/ethnicity, level of education, hospi-
talization in the past 12 months, body site of S. aureus infec-
tion, comorbidities (Charlson Co-morbidity Index), HIV
infection, number of visits (if any) to healthcare providers for
S. aureus prior to admission, and duration of symptoms prior
to admission. A study physician confirmed that the subject
was diagnosed with a skin infection and swabs were taken
from the infected site and nasal, axillary, inguinal and rectal
areas. Swabs were then analysed for the presence of
methicillin-resistant or methicillin-susceptible S. aureus using
standard microbiological techniques and enrichment-selective
media for S. aureus and MRSA.
Case definitions
Antimicrobial susceptibility was determined using the VITEK
system (BioMerieux USA, Durham, NC, USA), according to
NCCLS protocols; isolates resistant to oxacillin were consid-
ered MRSA; isolates susceptible to oxacillin were considered
methicillin-susceptible S. aureus (MSSA).
Subjects were considered to have CA infection if the cul-
ture specimen was not from a surgical site and if, in the past
12 months, the subject (i) had not resided in a long-term care
facility, such as a nursing home; (ii) had no indwelling devices,
such as an intravenous catheter; (iii) had not visited an infusion
clinic; and (iv) had not received peritoneal or haemodialysis.
Any subjects who did not fulfil these criteria were classified as
having HA infection. This definition is consistent with the
CDC and Prevention’s ABC criteria, as previously described
[6,13]. These criteria allowed categorization of all cases as
CA-MRSA, CA-MSSA, HA-MRSA or HA-MSSA. Colonization
was defined as the presence of the same type of organism that
caused infection (either MRSA or MSSA) colonizing a non-
infected body site.
Data analysis
The dataset of risk factors associated with MRSA coloniza-
tion among patients with CA-MRSA SSTIs was managed using
SAS (version 9.1.3; SAS Institute, Cary, NC, USA). Bivariate
analysis was used to compare 16 variables (Table 2) hypothe-
sized a priori to be associated with MRSA colonization among
patients with CA-MRSA SSTIs. Bivariate analysis was assessed
using odds ratios and the associated p-values. All variables
with a p-value £0.20 in the bivariate analyses were included
in a multivariate logistic regression analysis. Multicolinearity
was assessed for all models using a macro developed for use
with the SAS system. Multivariate analysis was conducted to
assess variables associated with MRSA colonization. Back-
wards elimination was performed using the Likelihood Ratio
test to find the best model. Models were examined for
goodness of fit using the Hosmer–Lemeshow statistic. All
variables were considered significant at the a = 0.05 level.
Results
One hundred and seventeen patients were enrolled in this
investigation. Some were later excluded from analysis for the
following reasons: six patients’ cultures were determined to
be coagulase-negative Staphylococcus upon further testing; six
agreed to enrol but then refused all colonization swabs; and
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six patients’ cultures were determined not to be associated
with a SSTI. Among the 99 patients with a SSTI included in
the analysis, 65 were determined to have CA-MRSA, 22 had
CA-MSSA, six had HA-MRSA, and six had HA-MSSA. Eight
(8%) patients were enrolled as outpatients from the HIV
clinic. Ninety-three (94%) of the patients presented to medi-
cal care primarily for a SSTI. The demographics for patients
in each of the four groups are summarized in Table 1.
Among patients with CA-MRSA SSTIs, the mean age was
39 years, and 76% were male. The demographics of patients
with CA-MRSA are summarized in Table 2.
Colonization
Among patients with a CA-MRSA SSTI, 37% (24/65) were
found to be MRSA colonized (Fig. 1a). Twenty-five percent
of patients (16/65) were colonized in the nares, 6% (4/65)
in the axilla, 17% (11/64) in the inguinal area, and 13% (7/
54) in the rectal area. Among those CA-MRSA-infected
patients who were MRSA colonized, 96% (23/24) could be
identified using a combination of nasal and inguinal screen-
ing alone. Of patients with CA-MSSA, HA-MRSA and
HA-MSSA, only 6% (2/34) had colonization outside the
nasal area (Fig. 1b–d).
TABLE 1. Demographic information concerning all patients with skin and soft tissue infections
Variable
All patients
n = 99 (%)
CA-MRSA SSTI
n = 65 (%)
CA-MSSA SSTI
n = 22 (%)
HA-MRSA
n = 6 (%)
HA-MSSA
n = 6 (%) p-value
Age, mean ± SD 40 ± 12 39 ± 12 46 ± 12 40 ± 20 37 ± 10 0.07
Gender male 75 (76) 49 (75) 17 (77) 4 (67) 5 (83) 0.94
Ethnicity
Caucasian 37 (37) 32 (49) 3 (14) 1 (17) 1 (17) 0.03
African–American 20 (20) 12 (19) 4 (18) 2 (33) 2 (33)
Hispanic 36 (36) 18 (28) 13 (59) 2 (33) 3 (50)
Other 6 (6) 3 (5) 2 (9) 1 (17) 0 (0)
CA, community-associated; HA, healthcare associated; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive S. aureus; SSTI, skin and soft tissue infec-
tion.
p-values represent comparisons amongst the four patient groups (CA-MRSA, CA-MSSA, HA-MRSA, HA-MSSA) were made via t-test or Fisher’s exact test, as appropriate.
TABLE 2. Demographic and clinical characteristics of subjects with CA-MRSA skin and soft tissue infections
Variable
All patients
n = 65 (%)
MRSA
colonization
n = 24 (%)
No MRSA
colonization
n = 41 (%) OR 95% CI p-value
Demographic variables
Age, mean ± SD 39 ± 12 40 ± 13 40 ± 12 0.99 0.95–1.04 0.67
Gender male 49 (75) 21 (89) 28 (68) 3.3 0.82–12.9 0.08
Ethnicity
Caucasian 32 (49) 13 (54) 19 (46) Ref – –
African–American 12 (19) 5 (21) 7 (17) 1.04 0.27–4.02 0.95
Hispanic 18 (28) 5 (21) 13 (32) 0.56 0.16–1.9 0.37
Other 3 (5) 1 (4) 2 (5) 0.73 0.06–8.9 0.81
Education
College graduate 10 (16) 4 (10) 4 (10) Ref – –
High school graduate 40 (62) 15 (63) 25 (61) 0.4 0.10–1.7 0.21
Did not graduate high school 15 (23) 3 (13) 12 (29) 0.17 0.03–0.99 0.05
Clinical
Charlston comorbidity score
Mean ± SD 1.7 ± 2.5 2.6 ± 2.9 1.2 ± 2.0 1.3 1.02–1.5 0.03
HIV positive 14 (21) 9 (38) 5 (12) 4.3 1.2–15.1 0.02
In the last 12 months
Previous MRSA infection 21 (32) 11 (46) 10 (24) 2.6 0.89–7.7 0.07
Use of antibiotics 27 (42) 10 (42) 17 (42) 2.0 0.60–6.6 0.99
Hospitalization 14 (22) 7 (29) 7 (17) 1.4 0.56–3.3 0.25
Incarceration 18 (28) 7 (29) 11 (27) 1.1 0.37–3.4 0.84
Intravenous drug use 13 (20) 5 (21) 8 (20) 1.1 0.31–3.8 0.99
Snort/sniff drugs 11 (17) 7 (29 4 (10) 3.8 0.98–14.7 0.08
Any drug use 23 (35) 12 (50) 11 (27) 2.7 0.95–7.8 0.06
‡2 sexual partners 14 (22) 3 (13) 11 (27) 0.39 0.10–1.6 0.18
Homelessness 21 (32) 6 (25) 15 (37) 0.61 0.22–1.7 0.34
In the past 30 days
Contact with person who had a skin infection 8 (12) 1 (4) 7 (17) 0.21 0.02–1.8 0.24
CA, community-associated; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive S. aureus; ref, referent group.
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FIG. 1. Prevalence of Staphylococcus aureus colonization in patients with skin or soft tissue infection. The bar graph height indicates the percent-
age colonized out of the total number of patients with each type of infection (CA-MRSA, CA-MSSA, HA-MRSA, or HA-MSSA). Nineteen patients
refused rectal swabbing (nine with CA-MRSA and three each with HA-MRSA, CA-MSSA, and HA-MSSA). One patient (in the CA-MRSA group)
refused inguinal swabbing. CA, community-associated; HA, healthcare-associated; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methi-
cillin-susceptible S. aureus.
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Risk factors for MRSA colonization in adults
Among patients with CA-MRSA, HIV infection (OR 4.3, p
0.02) and greater comorbidities (OR 1.3, p 0.03) were asso-
ciated with MRSA colonization (Table 2). Patients who did
not graduate from high school were found to have a signifi-
cantly lower prevalence of colonization (OR 0.17, p 0.05).
Factors not associated with MRSA colonization included pre-
vious antibiotic exposure, hospitalization, incarceration, and
drug use. Upon multivariate analysis (Table 3), HIV infection
(OR 5.8, p 0.01) and history of MRSA infection in the past
12 months (OR 3.6, p 0.03) were both found to be indepen-
dently associated with MRSA colonization.
Discussion
In a four-body-site survey, we detected MRSA colonization
in patients with acute CA-MRSA infection in 40% of patients.
Other notable findings include that non-nasal colonization
was much more common in patients with CA-MRSA SSTIs
compared with those with non-CA-MRSA S. aureus SSTIs.
This proportion of CA-MRSA patients who were colonized
is in contrast to the findings in HA-MRSA infections, in which
the vast majority of patients are colonized at the time of
infection [14]. The low number of patients with HA-MRSA
infections who were MRSA colonized might have resulted
from our patients being essentially outpatients with HA-
MRSA, a group in which colonization prevalence is poorly
understood. Nevertheless, the findings that MRSA coloniza-
tion is more common in CA-MRSA than in HA-MRSA sup-
ports observational data of CA-MRSA pathogenesis, and may
have clinical and pathogenetic significance. For example, dur-
ing outbreaks, CA-MRSA infection has frequently been
acquired via skin–skin or skin–fomite contact [2,9], suggest-
ing that non-nasal CA-MRSA may be important in CA-MRSA
acquisition or transmission. At a basic level, the genome of
the USA300 subtype of CA-MRSA, the most common circu-
lating strain of CA-MRSA nationwide and at our institution
[7,18], may help facilitate this spread. USA300 strains com-
monly contain the arginine catabolic mobile element (ACME),
which is believed to promote survival on human skin. ACME
is uncommonly found in other strains of S. aureus [15].
Interestingly, almost all CA-MRSA-colonized patients (96%;
25/26) in this study could be identified using a combination
of nasal and inguinal swabs (Fig. 1). Previous investigations
[16], which have rarely focused on CA-MRSA, have found
that S. aureus colonization is most common in the anterior
nares. These findings suggest that CA-MRSA colonizes a
more diverse array of body sites than non-CA-MRSA [17]. In
our population, screening for colonization in the axilla and
rectum in patients with CA-MRSA did not significantly
increase sensitivity in detecting MRSA colonization. Although
we did not screen for CA-MRSA colonization in the pharynx,
other studies have suggested that the pharynx may be an
additional site of CA-MRSA colonization [18].
In our population, colonization of patients with CA-MRSA
infection appears to be different from that of patients
infected with HA-MRSA, HA-MSSA or CA-MSSA, as 23%
(15/65) of patients with CA-MRSA were MRSA-colonized in
non-nasal areas. This contrasts with the 0% (0/22) of patients
with CA-MSSA, 17% (1/6) of patients with HA-MRSA, and
17% (1/6) of patients with HA-MSSA who were colonized
outside the nose.
Colonization studies often sample only one location on
the body, usually the anterior nares. The adequacy of this
screening technique has been questioned [19]. From our
findings, it appears that screening only the anterior nares
may be sufficient to detect most colonized patients who
have healthcare-associated S. aureus and CA-MSSA infections.
The low prevalence of colonization (1/22, 4.5%) among
patients with CA-MSSA infection is surprising, and may be
attributable to the frequent use of clindamycin for skin infec-
tions in our institution. Our colonization cultures were typi-
cally not obtained until 48–72 h after antibiotics had been
started. Clindamycin, which has been demonstrated to be
efficacious in nares decolonization [20], may have rendered
some patients with acute S. aureus infection negative upon
nasal sampling for colonization. The high prevalence of non-
nasal colonization in patients with CA-MRSA suggests that
decolonization regimens for patients with recurrent infec-
tions (the efficacy of which remains relatively unproven)
should probably include body washes such as chlorhexidine
or hexachlorophene, or diluted bleach baths [21].
There are several limitations to this study. First, all of the
patients were enrolled from a single medical centre, and
therefore the results may not be generalizable to other pop-
ulations. However, the patient population at Harbor-UCLA
Medical Center has ethnic and socioeconomic diversity. Sec-
ond, we did not enrol patients on a consecutive basis,
because of limited availability of study personnel. However,
TABLE 3. Multivariate analysis predicting MRSA colonization
among patients with CA-MRSA skin and soft tissue infections
(n = 65)
Variable OR 95% CI p-value
HIV status 5.8 1.5–22.3 0.01
Previous MRSA infection 3.6 1.1–11.8 0.03
CA, community-acquired; MRSA, methicillin-resistant Staphylococcus aureus.
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given the observational nature of the study, it is unlikely that
selection bias significantly influenced our findings. Third, we
relied on patient self-reporting to identify risk factors and
associations. Patients may be less than forthcoming about
risk factors such as incarceration, drug use or sexual contact.
Nevertheless, in a previous investigation using this instru-
ment, risk factors that may be considered socially undesir-
able were significantly associated with MRSA risk [6],
suggesting that the survey has validity and limited bias.
Fourth, we did not further characterize the S. aureus isolates.
However, previous studies in this population at our institu-
tion have shown that >90% of CA-MRSA isolates are
USA300 SCCmec Type IV-containing strains [22], the most
commonly circulating CA-MRSA strain in the USA, whereas
isolates of CA-MSSA are heterogeneous in terms of strain
type [6].
A further limitation is that patients were not approached
until they had received antibiotics, given that identification of
S. aureus from a wound culture typically takes up to 1–
2 days. However, prior systemic antibiotic therapy is unlikely
to alter the results significantly, because most systemic anti-
biotics, with the exception of clindamycin, active against
S. aureus are poor at eradicating colonization even after pro-
longed courses [23]. The investigation is also limited because
it is cross-sectional, and does not distinguish between coloni-
zation leading to infection and colonization as a result of
infection.
There are several strengths to the investigation. First,
whereas virtually all other studies on MRSA colonization
focus solely on the anterior nares, we screened for coloniza-
tion at four different body sites, increasing the sensitivity of
our assay. The traditional method of screening only the ante-
rior nares identified only 67% (16/24) of CA-MRSA-colonized
patients that were identified using four site screening (Fig. 1).
This difference in sensitivity suggests that future investiga-
tions should probably include inguinal screening in addition
to nasal screening for CA-MRSA colonization. Second, the
investigation was performed prospectively, and patients were
interviewed before the antibiotic susceptibility of the
S. aureus isolate was known, reducing the likelihood of
observer or recall bias. Third, we used a very rigorous defi-
nition of CA and HA infection. This definition is consistent
with CDC definitions and can be accurately defined only by
a combination of clinical information and information
obtained from patient survey. Therefore, unlike categories of
CA and HA derived from databases, our categorization of
patients into CA and HA categories is very accurate.
In conclusion, we found that MRSA colonization in
patients with acute CA-MRSA infection is present in less
than half and that nearly all colonized patients can be
identified using nasal and inguinal screening alone. We also
found that, unlike CA-MRSA, non-nasal colonization among
patients with HA-MRSA, CA-MSSA and HA-MSSA infections
is uncommon. Longitudinal studies would further clarify the
role of colonization in the pathogenesis of CA-MRSA and
other categories of S. aureus infection. Furthermore, under-
standing the role that non-nasal colonization plays as a reser-
voir for CA-MRSA transmission and re-infection would help
to determine the clinical significance of non-nasal coloniza-
tion.
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